Michele Tubiana-Hulin

Summary

Country: France

Publications

  1. ncbi Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
    M Tubiana-Hulin
    Department of Medical Oncology, Centre Rene Huguenin, Saint Cloud, France
    Ann Oncol 17:1228-33. 2006
  2. ncbi Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial
    Michele Tubiana-Hulin
    Departments of Medical Oncology, Centre Rene Huguenin, 35 rue daily, 92210 St Cloud, France
    Anticancer Res 27:2689-96. 2007
  3. ncbi First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study
    Djelila Allouache
    Centre F Baclesse, Lion Sur Mer, 14076 Caen Cedex 05, France
    BMC Cancer 5:151. 2005
  4. ncbi Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis
    Michele Tubiana-Hulin
    Department of Medical Oncology, Centre Rene Huguenin, 35 rue daily, 92210 Saint Cloud, France
    Crit Rev Oncol Hematol 71:12-21. 2009
  5. ncbi Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value
    Frederique Spyratos
    Laboratoire d Oncobiologie, Centre Rene Huguenin, Saint Cloud, France
    Cancer 94:2151-9. 2002
  6. ncbi Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer
    Veronique Dieras
    Institut Curie, Department of Medical Oncology, 26 Rue d Ulm, 75005 Paris, France
    J Clin Oncol 22:4958-65. 2004
  7. ncbi Immunomarker studies of fine-needle cytopuncture cell blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma
    Veronique Becette
    Departments of Pathology Medical Oncology Oncogenetics, Institut Curie Hôpital René Huguenin, Saint Cloud, France
    Breast J 17:121-8. 2011
  8. ncbi Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia
    Frédérique Cvitkovic
    Centre Rene Huguenin, Saint Cloud, France
    Cancer J 12:47-53. 2006
  9. ncbi A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Applied Cancer Research Institution for Translational Research Vienna ACR ITR VIEnna, Vienna, Austria
    J Cancer Res Clin Oncol 134:125-35. 2008
  10. ncbi Identification of molecular apocrine breast tumours by microarray analysis
    Pierre Farmer
    Swiss Institute of Bioinformatics, Lausanne, Switzerland
    Oncogene 24:4660-71. 2005

Collaborators

Detail Information

Publications10

  1. ncbi Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
    M Tubiana-Hulin
    Department of Medical Oncology, Centre Rene Huguenin, Saint Cloud, France
    Ann Oncol 17:1228-33. 2006
    ..We compared the impact of neoadjuvant chemotherapy on pathologic response and outcome in operable invasive lobular breast carcinoma (ILC) and invasive ductal breast carcinoma (IDC)...
  2. ncbi Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial
    Michele Tubiana-Hulin
    Departments of Medical Oncology, Centre Rene Huguenin, 35 rue daily, 92210 St Cloud, France
    Anticancer Res 27:2689-96. 2007
    ..Neoadjuvant hormonotherapy has recently been used for downstaging large or locally advanced (LA) breast cancer in postmenopausal women...
  3. ncbi First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study
    Djelila Allouache
    Centre F Baclesse, Lion Sur Mer, 14076 Caen Cedex 05, France
    BMC Cancer 5:151. 2005
    ..This phase II study evaluated the efficacy and safety of gemcitabine (G) plus paclitaxel (T) as first-line therapy in recurrent or metastatic breast cancer...
  4. ncbi Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis
    Michele Tubiana-Hulin
    Department of Medical Oncology, Centre Rene Huguenin, 35 rue daily, 92210 Saint Cloud, France
    Crit Rev Oncol Hematol 71:12-21. 2009
    ..When an ONJ occurs, the management should be adapted according to its extent. Thereby, a customization of BP therapy should be applied taking into account the aggressiveness of the underlying disease...
  5. ncbi Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value
    Frederique Spyratos
    Laboratoire d Oncobiologie, Centre Rene Huguenin, Saint Cloud, France
    Cancer 94:2151-9. 2002
    ..The objectives of this study were to compare MIB-1 evaluation to other methods of measuring cell proliferation, with a view to refining the cutoff used to classify tumors with low and high proliferation rates in therapeutic trials...
  6. ncbi Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer
    Veronique Dieras
    Institut Curie, Department of Medical Oncology, 26 Rue d Ulm, 75005 Paris, France
    J Clin Oncol 22:4958-65. 2004
    ....
  7. ncbi Immunomarker studies of fine-needle cytopuncture cell blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma
    Veronique Becette
    Departments of Pathology Medical Oncology Oncogenetics, Institut Curie Hôpital René Huguenin, Saint Cloud, France
    Breast J 17:121-8. 2011
    ....
  8. ncbi Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia
    Frédérique Cvitkovic
    Centre Rene Huguenin, Saint Cloud, France
    Cancer J 12:47-53. 2006
    ..Therefore, we conducted an exploratory, randomized, double-blind trial that compared the efficacy and safety of gallium nitrate and pamidronate in hospitalized patients with cancer-related hypercalcemia...
  9. ncbi A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Applied Cancer Research Institution for Translational Research Vienna ACR ITR VIEnna, Vienna, Austria
    J Cancer Res Clin Oncol 134:125-35. 2008
    ..Due to comparable effectiveness of the 5-day regimen which is widely used by others and the 3-day premedication tested in this trial the latter proved to be more favourable and was therefore recommended for future therapies...
  10. ncbi Identification of molecular apocrine breast tumours by microarray analysis
    Pierre Farmer
    Swiss Institute of Bioinformatics, Lausanne, Switzerland
    Oncogene 24:4660-71. 2005
    ..Our data show that it is possible with microarray data to divide mammary tumour cells into three groups based on steroid receptor activity: luminal (ER+ AR+), basal (ER- AR-) and molecular apocrine (ER- AR+)...